---
figid: PMC5993488__koni-07-07-1445458-g003
figlink: /pmc/articles/PMC5993488/figure/f0002b/
number: F2b
caption: Cumulative HLA class I and APM defects across gliomas from TCGA. (A) 213/396 GBM
  and (B) 166/511 LGG samples were found to have alterations in the formation of the
  HLA class I peptide complex that enable glioma cells to escape immune recognition
  by CD8+ T-cells. (C) Highlighted in red are the components showing different types
  of alterations in antigen processing and presentation ranging from defects in the
  IFN-γ pathway (JAK1, JAK2, STAT1) and the HLA class I enhanceosome (NLRC5, CIITA,
  IRF1, RFX5, RFXANK, RFXAP, X2BP, NF-Y) that mediate the transcriptional activation
  of HLA class I genes; PSME1, PSME2, PSME3 genes coding for the alpha, beta, and
  gamma subunits that make up the proteasome activator complex PA28 for peptide generation;
  ERAP1 and ERAP2 that trim longer precursor of antigenic peptides; HSPA and HSPC
  that chaperones the peptides to their loading on the MHC class I in the endoplasmic
  reticulum; and TAP1, TAP2, TAPBP, calreticulin, calnexin, PDIA3, β2-microglobulin
  and HLA class I genes that participate in the formation of the MHC class I peptide
  complex.
pmcid: PMC5993488
papertitle: The possibility of cancer immune editing in gliomas. A critical review.
reftext: Víctor A. Arrieta, et al. Oncoimmunology. 2018;7(7):e1445458.
pmc_ranked_result_index: '201678'
pathway_score: 0.8990305
filename: koni-07-07-1445458-g003.jpg
figtitle: Cumulative HLA class I and APM defects across gliomas from TCGA
year: '2018'
organisms:
- Homo sapiens
ndex: c86b7732-df13-11ea-99da-0ac135e8bacf
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC5993488__koni-07-07-1445458-g003.html
  '@type': Dataset
  description: Cumulative HLA class I and APM defects across gliomas from TCGA. (A)
    213/396 GBM and (B) 166/511 LGG samples were found to have alterations in the
    formation of the HLA class I peptide complex that enable glioma cells to escape
    immune recognition by CD8+ T-cells. (C) Highlighted in red are the components
    showing different types of alterations in antigen processing and presentation
    ranging from defects in the IFN-γ pathway (JAK1, JAK2, STAT1) and the HLA class
    I enhanceosome (NLRC5, CIITA, IRF1, RFX5, RFXANK, RFXAP, X2BP, NF-Y) that mediate
    the transcriptional activation of HLA class I genes; PSME1, PSME2, PSME3 genes
    coding for the alpha, beta, and gamma subunits that make up the proteasome activator
    complex PA28 for peptide generation; ERAP1 and ERAP2 that trim longer precursor
    of antigenic peptides; HSPA and HSPC that chaperones the peptides to their loading
    on the MHC class I in the endoplasmic reticulum; and TAP1, TAP2, TAPBP, calreticulin,
    calnexin, PDIA3, β2-microglobulin and HLA class I genes that participate in the
    formation of the MHC class I peptide complex.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - HSPA2
  - ATF2
  - CD8B
  - HSPA4
  - CD8A
  - HSPA1B
  - CREB1
  - HSPA4L
  - HSPA1A
  - HYOU1
  - HSPA1L
  - CIITA
  - HSPA12A
  - PSMA7
  - HSPH1
  - HSPA12B
  - HSPA13
  - CREB3L2
  - IFNA1
  - IRF1
  - ATF1
  - TAPBP
  - TAP2
  - PDIA3
  - HSPA8
  - HSPA9
  - HSPA14
  - CREM
  - CREB3L4
  - HSPA5
  - CREB3
  - JAK2
  - PSMB9
  - CREB3L3
  - PSMB8
  - ERAP2
  - HSPA6
  - NFYA
  - PSME1
  - CREB5
  - CREB3L1
  - TCR
  - TAPI
  - Glioma
genes:
- word: HSPA
  symbol: HSPA
  source: bioentities_symbol
  hgnc_symbol: HSPA2
  entrez: '3306'
- word: (CREB)
  symbol: CREB
  source: bioentities_symbol
  hgnc_symbol: ATF2
  entrez: '1386'
- word: CD8*
  symbol: CD8
  source: bioentities_symbol
  hgnc_symbol: CD8B
  entrez: '926'
- word: HSPA
  symbol: HSPA
  source: bioentities_symbol
  hgnc_symbol: HSPA4
  entrez: '3308'
- word: CD8*
  symbol: CD8
  source: bioentities_symbol
  hgnc_symbol: CD8A
  entrez: '925'
- word: HSPA
  symbol: HSPA
  source: bioentities_symbol
  hgnc_symbol: HSPA1B
  entrez: '3304'
- word: (CREB)
  symbol: CREB
  source: bioentities_symbol
  hgnc_symbol: CREB1
  entrez: '1385'
- word: HSPA
  symbol: HSPA
  source: bioentities_symbol
  hgnc_symbol: HSPA4L
  entrez: '22824'
- word: HSPA
  symbol: HSPA
  source: bioentities_symbol
  hgnc_symbol: HSPA1A
  entrez: '3303'
- word: HSPA
  symbol: HSPA
  source: bioentities_symbol
  hgnc_symbol: HYOU1
  entrez: '10525'
- word: HSPA
  symbol: HSPA
  source: bioentities_symbol
  hgnc_symbol: HSPA1L
  entrez: '3305'
- word: IRF1,CIITA,NURCSgene
  symbol: CIITA
  source: hgnc_symbol
  hgnc_symbol: CIITA
  entrez: '4261'
- word: HSPA
  symbol: HSPA
  source: bioentities_symbol
  hgnc_symbol: HSPA12A
  entrez: '259217'
- word: HSPC
  symbol: HSPC
  source: hgnc_alias_symbol
  hgnc_symbol: PSMA7
  entrez: '5688'
- word: HSPA
  symbol: HSPA
  source: bioentities_symbol
  hgnc_symbol: HSPH1
  entrez: '10808'
- word: HSPA
  symbol: HSPA
  source: bioentities_symbol
  hgnc_symbol: HSPA12B
  entrez: '116835'
- word: HSPA
  symbol: HSPA
  source: bioentities_symbol
  hgnc_symbol: HSPA13
  entrez: '6782'
- word: (CREB)
  symbol: CREB
  source: bioentities_symbol
  hgnc_symbol: CREB3L2
  entrez: '64764'
- word: IFN
  symbol: IFN
  source: hgnc_alias_symbol
  hgnc_symbol: IFNA1
  entrez: '3439'
- word: IRF1,
  symbol: IRF1
  source: hgnc_symbol
  hgnc_symbol: IRF1
  entrez: '3659'
- word: (CREB)
  symbol: CREB
  source: bioentities_symbol
  hgnc_symbol: ATF1
  entrez: '466'
- word: (TAPBP)
  symbol: TAPBP
  source: hgnc_symbol
  hgnc_symbol: TAPBP
  entrez: '6892'
- word: TAP2
  symbol: TAP2
  source: hgnc_symbol
  hgnc_symbol: TAP2
  entrez: '6891'
- word: ERP57/
  symbol: ERp57
  source: hgnc_alias_symbol
  hgnc_symbol: PDIA3
  entrez: '2923'
- word: HSPA
  symbol: HSPA
  source: bioentities_symbol
  hgnc_symbol: HSPA8
  entrez: '3312'
- word: HSPA
  symbol: HSPA
  source: bioentities_symbol
  hgnc_symbol: HSPA9
  entrez: '3313'
- word: HSPA
  symbol: HSPA
  source: bioentities_symbol
  hgnc_symbol: HSPA14
  entrez: '51182'
- word: (CREB)
  symbol: CREB
  source: bioentities_symbol
  hgnc_symbol: CREM
  entrez: '1390'
- word: (CREB)
  symbol: CREB
  source: bioentities_symbol
  hgnc_symbol: CREB3L4
  entrez: '148327'
- word: HSPA
  symbol: HSPA
  source: bioentities_symbol
  hgnc_symbol: HSPA5
  entrez: '3309'
- word: (CREB)
  symbol: CREB
  source: bioentities_symbol
  hgnc_symbol: CREB3
  entrez: '10488'
- word: JAK2
  symbol: JAK2
  source: hgnc_symbol
  hgnc_symbol: JAK2
  entrez: '3717'
- word: LMP2
  symbol: LMP2
  source: hgnc_prev_symbol
  hgnc_symbol: PSMB9
  entrez: '5698'
- word: (CREB)
  symbol: CREB
  source: bioentities_symbol
  hgnc_symbol: CREB3L3
  entrez: '84699'
- word: LMP7
  symbol: LMP7
  source: hgnc_prev_symbol
  hgnc_symbol: PSMB8
  entrez: '5696'
- word: ERAP2
  symbol: ERAP2
  source: hgnc_symbol
  hgnc_symbol: ERAP2
  entrez: '64167'
- word: HSPA
  symbol: HSPA
  source: bioentities_symbol
  hgnc_symbol: HSPA6
  entrez: '3310'
- word: NF-YA
  symbol: NF-YA
  source: hgnc_alias_symbol
  hgnc_symbol: NFYA
  entrez: '4800'
- word: PSME1)
  symbol: PSME1
  source: hgnc_symbol
  hgnc_symbol: PSME1
  entrez: '5720'
- word: (CREB)
  symbol: CREB
  source: bioentities_symbol
  hgnc_symbol: CREB5
  entrez: '9586'
- word: (CREB)
  symbol: CREB
  source: bioentities_symbol
  hgnc_symbol: CREB3L1
  entrez: '90993'
chemicals:
- word: TCR
  source: MESH
  identifier: D017260
- word: TAPI
  source: MESH
  identifier: C099410
diseases:
- word: Glioma
  source: MESH
  identifier: D005910
figid_alias: PMC5993488__F2b
redirect_from: /figures/PMC5993488__F2b
figtype: Figure
---
